Reproducible leukocytoclastic vasculitis following severe acute respiratory syndrome coronavirus 2 vaccination

J Dermatol. 2022 Apr;49(4):145-146. doi: 10.1111/1346-8138.16282. Epub 2022 Feb 9.

Authors

Thilo Gambichler¹, Nessr Abu Rached¹, Lisa Scholl¹, Bertold Behle¹, Rita Mansour¹, Manuel Nick¹, Laura Susok¹

Affiliation

¹ Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.

No abstract available

Publication types

Letter

MeSH terms

COVID-19* / prevention & control
Humans
SARS-CoV-2
Vaccination
Vasculitis, Leukocytoclastic, Cutaneous* / diagnosis
Vasculitis, Leukocytoclastic, Cutaneous* / etiology

Supplementary concepts

Erythema elevatum diutinum